Novartis agrees to pay $25 Million to settle charges it bribed Chinese healthcare professionals

Novartis Pharmaceuticals was charged with violations of the Foreign Corrupt Practices Act for making illegal payments to healthcare providers in China. Similar charges are pending in Korea. According to the SEC, the Sandoz unit made payments to healthcare professionals to reward them for prescribing a particular drug, including covering their charges at strip clubs.

Featured Posts
Recent Posts